Technology / Scientific & Technical InstrumentsJakartaID
$336.00
+24.00 (+7.69%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $695.3M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
18/100
F
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$224.0B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-7.4%
↓Gross Margin
32.4%
↑Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2018–2025 · 7 años de histórico normalizado
Revenue CAGR
-25.4%
FCF CAGR
-34.5%
FCF margin
12.7%
FCF / Net income
-0.22x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.49B · net income $-3.18B · FCF $695.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | $5.49B | $5.49B | $10.19B | $16.16B | $15.21B | $11.29B | $19.80B | $68.39B | $42.58B |
| Net Income | $-3.18B | $-3.18B | $-5.82B | $28.8M | $90.3M | $-3.81B | $-1.26B | $13.02B | $12.26B |
| EBITDA | $-703.9M | $-703.9M | $-5.72B | $2.74B | $1.83B | $-2.58B | $63.7M | $18.28B | $18.77B |
| EPS | -4.76 | -4.76 | -8.73 | 0.04 | 0.14 | -6.71 | -1.90 | 19.53 | 18.39 |
| Gross Margin | 32.4% | 32.4% | 35.9% | 55.2% | 45.4% | 44.4% | 42.4% | 35.5% | 55.7% |
| Operating Margin | -41.6% | -41.6% | -68.6% | 1.0% | -18.8% | -29.9% | -0.9% | 24.6% | 43.5% |
| Net Margin | -57.8% | -57.8% | -57.1% | 0.2% | 0.6% | -33.7% | -6.4% | 19.0% | 28.8% |
| Balance Sheet | |||||||||
| Debt/Equity | 0.00 | 0.00 | 0.04 | 0.03 | 0.02 | 0.01 | 0.05 | 0.06 | 0.17 |
| Current Ratio | 10.51 | 10.51 | 4.71 | 4.98 | 5.18 | 4.83 | 2.14 | 2.68 | 1.94 |
| Cash Flow | |||||||||
| Free Cash Flow | $695.3M | $695.3M | $-8.56B | $4.32B | $-7.71B | $-28.41B | $-7.11B | $9.44B | $13.45B |
| Returns | |||||||||
| ROE | -7.4% | -7.4% | -12.8% | 0.1% | 0.2% | -7.7% | -2.8% | 33.0% | 69.2% |
| Growth & Yield | |||||||||
| Revenue Growth | -46.1% | -46.1% | -37.0% | 6.2% | 34.7% | -43.0% | -71.0% | 60.6% | — |
| EPS Growth | 45.4% | 45.4% | -20315.2% | -68.1% | 102.0% | -253.6% | -109.7% | 6.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-8.73 → -4.76
Residual
-11.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.